Citi Sticks to Their Buy Rating for Haleon PLC (HLN)
Kepler Capital Reaffirms Their Buy Rating on Haleon PLC (HLN)
Haleon PLC (HLN) Receives a Buy From Citi
Haleon PLC (HLN) Receives a Buy From Barclays
Kepler Capital Reaffirms Their Buy Rating on Haleon PLC (HLN)
Haleon PLC: Strong Q4 Performance and Positive 2025 Outlook Justify Buy Rating
Barclays Lifts Haleon Price Target Amid FY24 'Top Tier' Earnings Quality
Kepler Capital Sticks to Its Buy Rating for Haleon PLC (HLN)
RBC Neutral on Haleon's Earnings Report; Rating, Price Target Unchanged
Haleon PLC: Solid Fundamentals but Limited Upside Potential – Hold Rating Maintained
Barclays Sticks to Their Buy Rating for Haleon PLC (HLN)
Morgan Stanley Downgrades Haleon(HLN.US) to Hold Rating, Cuts Target Price to $10.2
Berenberg Bank Maintains Haleon(HLN.US) With Buy Rating, Cuts Target Price to $11.41
Haleon PLC: Hold Recommendation Due to Premium Valuation and Limited Near-Term Upside
Haleon PLC (HLN) Receives a Buy From Barclays
Argus Research Maintains Haleon(HLN.US) With Buy Rating, Raises Target Price to $11.5
Haleon PLC: Promising Revenue Growth and Strategic Initiatives Drive Buy Rating
Berenberg Bank Maintains Haleon(HLN.US) With Buy Rating, Cuts Target Price to $11.77
Analysts' Opinions Are Mixed on These Healthcare Stocks: Haleon PLC Sponsored ADR (HLN), Insmed (INSM) and Galapagos (GLPG)
BofA Securities Maintains Haleon(HLN.US) With Buy Rating